WHO Immunization Expert Group Recommends Sanofi’s Dengue Vaccine For High-Prevalence Areas

Reuters: WHO group backs Sanofi’s vaccine in areas with high dengue rates
“The World Health Organization’s expert group on immunization said on Friday it recommended that countries consider introducing Sanofi’s dengue vaccine Dengvaxia in areas where prevalence of the virus was 50 percent or higher…” (Miles, 4/15).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.